Overview
- 8 inspections across 8 sites are on record.
- 9 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-06-07.
At a glance
Inspections
8
Sites
8
Observations
9
Career since
May 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Changzhou Yinsheng Pharmaceutical Co. Ltd. | 7 Jun 2024 | Human Drugs | On file |
| Changzhou Sunlight Pharmaceutical Co. Ltd. | 31 May 2024 | Human Drugs | On file |
| Nantong Jinghua Pharmaceutical Co., Ltd | 24 May 2024 | Human Drugs | |
| Synthon s.r.o. | 12 Jul 2023 | Human Drugs | On file |
| Eli Lilly Kinsale Limited | 24 May 2023 | Human Drugs |
Sites inspected
Changzhou Yinsheng Pharmaceutical Co. Ltd.Changzhou, China1 insp.
Changzhou Sunlight Pharmaceutical Co. Ltd.Changzhou, China1 insp.
Nantong Jinghua Pharmaceutical Co., LtdNantong, China1 insp.
Synthon s.r.o.Blansko, Czech Republic1 insp.
Eli Lilly Kinsale LimitedKinsale, Ireland1 insp.
Co-investigators
Investigators who share inspections with this person.
Robin P Mathew3 shared
Jing Fang1 shared
Andrew J Barrowcliff1 shared
Jeffrey P Raimondi1 shared
Sneha S Patel1 shared
Frank Wackes1 shared
Nancy M Espinal1 shared
Rebecca E Dombrowski1 shared
Rita K Kabaso1 shared
Michele Perry-Williams1 shared
Full investigator report
Get the verbatim findings behind Kshitij A Patkar's 9 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site